Therapix Biosciences Ltd (TRPX) - Financial and Strategic SWOT Analysis Review

  • ID: 4395079
  • SWOT Analysis
  • 36 pages
  • GlobalData
1 of 5
Therapix Biosciences Ltd (TRPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Therapix Biosciences Ltd (Therapix), formerly Nasvax Ltd is a clinical stage biopharmaceutical company that develops improved vaccines and immunotherapeutics. It specializes in the field of cannabinoid based pharmaceuticals for the treatment of central nervous system disorders. Therapix’s major candidates include THX-TS01 which targets the treatment of rare indication, Tourette's syndrome and THX-ULD01 which targets mild cognitive impairments. Its two major development programs Joint Pharma and BrainBright Pharma are based on repurposing a US FDA approved synthetic cannabinoid (dronabinol). The company conducts its clinical programs in collaboration with various pharma companies and institutions. Therapix Biosciences is headquartered in Tel Aviv, Israel.

Therapix Biosciences Ltd Key Recent Developments

Aug 10,2017: Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update
Jul 11,2017: CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
May 24,2017: Therapix Biosciences Announces CEO Change
May 03,2017: Therapix Biosciences announces the appointment of Josh Blacher as CFO
May 03,2017: Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
  • Therapix Biosciences Ltd - Key Facts
  • Therapix Biosciences Ltd - Key Employees
  • Therapix Biosciences Ltd - Key Employee Biographies
  • Therapix Biosciences Ltd - Major Products and Services
  • Therapix Biosciences Ltd - History
  • Therapix Biosciences Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Therapix Biosciences Ltd - Business Description
  • Therapix Biosciences Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Therapix Biosciences Ltd - Strengths
  • Therapix Biosciences Ltd - Weaknesses
  • Therapix Biosciences Ltd - Opportunities
  • Therapix Biosciences Ltd - Threats
  • Therapix Biosciences Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Therapix Biosciences Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 10, 2017: Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update
  • Jul 11, 2017: CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
  • May 24, 2017: Therapix Biosciences Announces CEO Change
  • May 03, 2017: Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer
  • Nov 03, 2016: Therapix Biosciences' Board of Directors is Joined by Stephen M. Simes
  • Jun 13, 2016: The Israeli Pharma Company Therapix, is Joined by Five Internationally Renowned Experts, From Israel and the World, in the Field of Psychiatry and Tourette
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Therapix Biosciences Ltd, Key Facts
  • Therapix Biosciences Ltd, Key Employees
  • Therapix Biosciences Ltd, Key Employee Biographies
  • Therapix Biosciences Ltd, Major Products and Services
  • Therapix Biosciences Ltd, History
  • Therapix Biosciences Ltd, Subsidiaries
  • Therapix Biosciences Ltd, Key Competitors
  • Therapix Biosciences Ltd, Ratios based on current share price
  • Therapix Biosciences Ltd, Annual Ratios
  • Therapix Biosciences Ltd, Annual Ratios (Cont...1)
  • Therapix Biosciences Ltd, Interim Ratios
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Therapix Biosciences Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Therapix Biosciences Ltd, Performance Chart (2012 - 2016)
  • Therapix Biosciences Ltd, Ratio Charts
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Rimonyx Pharmaceuticals Ltd
  • Compugen Ltd
  • BiondVax Pharmaceuticals Ltd
  • Bio-Cell Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll